Skip to content

8-KAccepted Sep 22, 5:36 PM ET

Ambrx Biopharma Inc. 8-K

Ambrx Biopharma Cayman, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:36 PM

Sep 22, 2023

Filed

Sep 25, 2023

Documents

13

Size

233.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.